Carto3系统指引零射线下导管射频消融治疗特发性室性心律失常的有效性和安全性

doi:10.3969/j.issn.1004-583X.2018.11.009

临床荟萃

Carto3系统指引零射线下导管射频消融治疗特发性室性心律失常的有效性和安全性

1.广西医科大学第一附属医院心血管内科，广西南宁 530021；2.柳州市工人医院心血管内科，
广西柳州 545005；3.桂林市人民医院心血管内科，广西桂林 541002

出版日期:2018-11-05 发布日期:2018-12-10
通讯作者: 通信作者：钟国强，Email: 645920840@qq.com
基金资助:
广西重点研发计划（桂科AB16380231）

Efficacy and safety of catheter radiofrequency ablation for idiopathic ventricular arrhythmia guided by Carto3 system without fluoroscopy

1. Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University,
Nanning 530021, China; 2.Department of Cardiology, Liuzhou Worker's Hospital, Liuzhou 545005;
3. Department of Cardiology,Guilin People's Hospital, Guilin 541002, China

Online:2018-11-05 Published:2018-12-10
Contact: Corresponding author: Zhong Guoqiang, Email: 645920840@qq.com

摘要/Abstract

摘要： 目的通过比较Carto3系统指引零射线与X线下导管射频消融治疗特发性室性心律失常，评估零射线方法的有效性和安全性。方法前瞻性收集由2017年1月至2018年3月于广西医科大学第一附属医院连续在Carto3系统指引下行导管射频消融术的特发性室性心律失常(包括特发性室性期前收缩和特发性室性心动过速)患者106例，根据手术日期的单双号进行分组。其中39例手术日为单号，纳入零射线组；67例手术日为双号，纳入射线组。所有手术均由2名术者完成，均使用强生导航星压力监测灌注消融导管。比较两组手术时间、首次标测时间、放电次数、放电时间、靶点位置、即刻成功率、并发症发生率、复发率。结果两组年龄、性别、病程、超声心动图等基线资料差异无统计学意义。射线组使用X线时间为168.0(44.8, 541.3) s。两组在手术一般资料方面，手术时间、首次标测时间、放电次数、放电时间、靶点位置等差异均无统计学意义。两组在手术的有效性和安全性方面，即刻成功率、并发症发生率、复发率方面差异均无统计学意义（P＞0.05）。结论 Carto3系统指引零射线下导管射频消融治疗特发性室性心律失常有效、安全，没有增加手术时间、首次标测时间及放电次数。

关键词: 心律失常, 心性, 导管消融术, X线

Abstract: Objective To compare the catheter radiofrequency ablation for idiopathic ventricular arrhythmia guided by Carto3 system with or without fluoroscopy, so as to evaluate the efficacy and safety of zero fluoroscopy approach.Methods A prospective study was performed among 106 consecutive patients of idiopathic ventricular arrhythmia (IVA, including idiopathic premature ventricular contraction and idiopathic ventricular tachycardia) who were hospitalized from January 2017 to March 2018 in the First Affiliated Hospital of Guangxi Medical University. The catheter radiofrequency ablation was performed under Carto3 system guidance.According to the date of operation, patients were randomly divided into two groups. Of them, 39 cases operated on odd numbers were included zero fluoroscopy group (ZF group), and 67 cases on double numbers were included in fluoroscopy group (F group). All the procedures were performed with contact force catheter of Biosense Webster by 2 operators. The difference between the two groups in terms of their procedure time, first mapping time, number of ablation, ablation time, fluoroscopy time, target position, immediate success rate, complications and recurrence rate were compared.Results There was no statistical difference in baseline data such as age, sex, disease course and echocardiographic index between the two groups. ZF group was performed completely without fluoroscopy, and the fluoroscopy time of F group was 168.0(44.8,541.3) s. In terms of general procedure data such as the procedure time, first mapping time, number of ablation, ablation time, target position, no statistical difference was found between the two groups. As to the effectiveness and safety of the operation between the two groups, the immediate success rate, complications and recurrence rate had no statistical difference（P＞0.05）.Conclusion Catheter radiofrequency ablation for idiopathic ventricular arrhythmias guided by Carto3 system without fluoroscopy showed efficacy and safety, without increasing the procedure time, the first mapping time, and the number of ablation.

Key words: arrhythmias, cardiac, catheter ablation , X-rays

王安1, 2, 文伟明1, 李金轶1, 何燕1, 蒋靖波3, 吕祥威1, 钟国强1. Carto3系统指引零射线下导管射频消融治疗特发性室性心律失常的有效性和安全性[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2018.11.009.

Wang An1, Wen Weiming1, Li Jinyi1, He Yan1, Jiang Jingbo2, Lv Xiangwei1, Zhong Guoqiang1. Efficacy and safety of catheter radiofrequency ablation for idiopathic ventricular arrhythmia guided by Carto3 system without fluoroscopy[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.11.009.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2018.11.009

https://huicui.hebmu.edu.cn/CN/Y2018/V33/I11/956

[1]	尚蒙, 王礼琳. 沙库巴曲/缬沙坦对慢性心力衰竭患者心律失常影响的研究进展[J]. 临床荟萃, 2023, 38(5): 459-464.
[2]	周子涵, 崔炜. 心血管系统常用药物对新型冠状病毒肺炎感染风险及不良预后的影响[J]. 临床荟萃, 2022, 37(10): 869-888.
[3]	李朝俊, 孙诚鸿, 金文宇. 非结核分枝杆菌肺病与耐多药肺结核的胸部CT征象对照分析[J]. 临床荟萃, 2021, 36(6): 530-534.
[4]	崔国艳, 郑雯, 张丽伟. 利多卡因联合瑞舒伐他汀治疗不耐受胺碘酮的急性冠状动脉综合征伴急性心律失常的临床疗效[J]. 临床荟萃, 2021, 36(4): 311-314.
[5]	关付1, 李广平1, 2. 无导线心脏起搏现状[J]. 临床荟萃, 2020, 35(6): 558-563.
[6]	董旭情, 冯琳, 王晓宁, 吴新华, 何娟. 儿童预激性心肌病4例并文献复习[J]. 临床荟萃, 2020, 35(11): 1015-1018.
[7]	迟红卫，门明，徐倩，冯文秋，任进军，陈艳芳，郭志军. CT靶扫描联合多平面重组对肺部＜1 cm磨玻璃结节诊断的应用价值[J]. 临床荟萃, 2019, 34(9): 823-826.
[8]	冯琳1，张秀芳2. 儿童遗传性心律失常的诊治进展[J]. 临床荟萃, 2019, 34(3): 207-211.
[9]	丁绍祥. 尖端扭转型室性心动过速与临床[J]. 临床荟萃, 2019, 34(3): 280-283.
[10]	苗成龙, 李拥军. 室性心动过速和心室颤动治疗进展[J]. 临床荟萃, 2018, 33(9): 753-756.
[11]	张建华1a，李俊霞1b，刘静2，王荣福1a. 核医学在炎症性肠病中的应用进展[J]. 临床荟萃, 2018, 33(8): 645-649.
[12]	徐倩, 郭志军, 冯文秋, 赵宝宏, 刘海涛, 蔺强. 多排螺旋CT心脏收缩期与舒张期对比测量研究[J]. 临床荟萃, 2018, 33(8): 678-682.
[13]	李洁1，崔俊玉2. 动态心电图临床操作标准化方法[J]. 临床荟萃, 2018, 33(12): 1018-1023.
[14]	余韬，舒徐. 胃间质瘤预后相关因素的临床研究进展[J]. 临床荟萃, 2018, 33(11): 1008-1012.
[15]	阚方功1a，马周鹏2，林观生2，周平1b. 肾透明细胞癌胰腺转移的CT诊断(附3例报告并文献复习)[J]. 临床荟萃, 2018, 33(10): 904-906,913.

Carto3系统指引零射线下导管射频消融治疗特发性室性心律失常的有效性和安全性

Efficacy and safety of catheter radiofrequency ablation for idiopathic ventricular arrhythmia guided by Carto3 system without fluoroscopy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价